Filing Details
- Accession Number:
- 0001567619-23-004548
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-06 19:30:28
- Reporting Period:
- 2023-03-02
- Accepted Time:
- 2023-03-06 19:30:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1653477 | Ingevity Corp | NGVT | Chemicals & Allied Products (2800) | 474027764 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1668926 | John Phillip Platt | C/O Ingevity Corporation 4920 O'Hear Ave, Suite 400 North Charleston SC 29405 | Cao & Vp, Bus Transform Lead | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-02 | 2,288 | $27.90 | 10,811 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-02 | 2,288 | $81.70 | 8,523 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-03-02 | 1,207 | $53.11 | 9,730 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-02 | 1,207 | $81.63 | 8,523 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-03-02 | 2,363 | $45.04 | 10,886 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-02 | 2,363 | $81.62 | 8,523 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-02 | 2,989 | $81.83 | 5,534 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2023-03-02 | 2,288 | $0.00 | 2,288 | $27.90 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2023-03-02 | 1,207 | $0.00 | 1,207 | $53.11 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2023-03-02 | 2,363 | $0.00 | 2,363 | $45.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-05-27 | No | 4 | M | Direct | |
| 0 | 2027-02-27 | No | 4 | M | Direct | |
| 0 | 2030-02-28 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.64 to $81.73, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.60 to $81.65, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.60 to $81.69, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option, representing a right to purchase a total of 2,288 shares, became fully vested and exercisable on February 27, 2019.
- The option, representing a right to purchase a total of 1,207 shares, became fully vested and exercisable on February 27, 2020.
- The option, representing a right to purchase a total of 2,363 shares, became fully vested and exercisable on February 28, 2023.
Billionaire Hedge Funds
